Hikma Pharmaceuticals PLC (Hikma) will announce its preliminary financial results for the year ended 31 December 2016 on Wednesday 15 March 2017.

LONDON, UK, 8 March 2017 - Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody’s / BB+ S&P, both stable), the fast growing pharmaceuticals company, will announce its preliminary financial results for the year ended 31 December 2016 on Wednesday 15 March 2017.

Press Release Corporate 8 March 2017

A presentation and webcast for analysts will be held at 9.30am GMT at Etc. Venues, 155 Bishopsgate, Liverpool St, London, EC2M 3YD.

To join via conference call please dial: +44 (0) 20 3003 2666

UK Toll Free Number: 0808 109 0700

The results presentation and a webcast recording of the event will be available on the Company's website at www.hikma.com or http://cache.merchantcantos.com/webcast/webcaster/4000/7464/16532/72130/Lobby/default.htm

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.